Predicting treatment failure in patients with community acquired pneumonia: A case-control study

Keyphrases

• Treatment Failure 100%
• Community-acquired Pneumonia 100%
• Interleukin-6 80%
• Early Failure 80%
• Late Failure 80%
• Hospitalization 40%
• Pleural Effusion 40%
• Multilobar 40%
• CURB-65 Score 40%
• Interleukin-1β 40%
• IL-6 Level 40%
• Failure Cases 40%
• Randomized Clinical Trial 20%
• Increased Mortality 20%
• Pneumonia Patients 20%
• Clinical Management 20%
• Trial Registration 20%
• Clinical Predictors 20%
• Interleukin-10 20%
• Interleukin-8 20%
• Excess Mortality 20%
• Non-failure 20%

Medicine and Dentistry

• Community-Acquired Pneumonia 100%
• Interleukin 6 100%
• Case-Control Study 100%
• Pleura Effusion 33%
• Interleukin 1 33%
• Mortality Rate 16%
• Clinical Management 16%
• Interleukin 10 16%
• Clinical Predictor 16%
• Tumor Necrosis Factor 16%
• Randomized Clinical Trials 16%

Immunology and Microbiology

• Interleukin 6 100%
• Interleukin 1 33%
• Mortality Rate 16%
• Interleukin 10 16%
• Tumor Necrosis Factor 16%
• Interleukin 8 16%